Camp4 Therapeutics Corporation(CAMP:US)
Market Cap$164.6M
Key Metrics
Price$3.17
Revenue (TTM)$3.93M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$86.3M
EBITDA (TTM)-$13.78M
Op. Margin (TTM)-1.32K%
Dividend Yield-
Holders Yield-
Cash on hand$99.21M
Total Assets$105.46M
Net Assets$30.9M
Total Debt$2.12M
Key Metrics
Price$3.17
Revenue (TTM)$3.93M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$86.3M
EBITDA (TTM)-$13.78M
Op. Margin (TTM)-1.32K%
Dividend Yield-
Holders Yield-
Cash on hand$99.21M
Total Assets$105.46M
Net Assets$30.9M
Total Debt$2.12M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.29M | $348K | $795K | $1.5M | $858K | $652K | $0 | $0 | $0 | $350K |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - |
| $14.37M | $13.12M | $13.95M | $14.53M | $13.96M | $14.69M | $13.52M | $12.66M | $13.48M | $12.69M | |
| Research and Development | $10.16M | $8.36M | $9.36M | $10.34M | $10.15M | $10M | $9.7M | $9.39M | $10.66M | $9.82M |
| Selling, General, and Administrative | $4.21M | $4.77M | $4.6M | $4.18M | $3.81M | $4.69M | $3.81M | $3.27M | $2.82M | $2.87M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$13.07M | -$12.78M | -$13.16M | -$13.03M | -$13.1M | -$14.03M | -$13.52M | -$12.66M | -$13.48M | -$12.34M |
| -$5.26M | -$27.51M | -$1.94M | $441K | $667K | $755K | $32K | $86K | $486K | $642K | |
| Non-Operating Interest Income | $910K | $710K | $423K | $453K | $588K | $610K | $94K | $231K | $569K | $689K |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | -$6.17M | -$28.22M | -$2.37M | -$12K | $79K | $145K | -$62K | -$145K | -$83K | -$47K |
Income Before Tax | -$18.33M | -$40.28M | -$15.1M | -$12.59M | -$12.43M | -$13.28M | -$13.48M | -$12.58M | -$12.99M | -$11.7M |
Income Tax | - | - | - | - | - | - | - | - | - | - |
Net Income | -$18.33M | -$40.28M | -$15.1M | -$12.59M | -$12.43M | -$13.28M | -$13.48M | -$12.58M | -$12.99M | -$11.7M |
Minority Interests | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$18.33M | -$40.28M | -$15.1M | -$12.59M | -$12.43M | -$13.28M | -$13.48M | -$12.58M | -$12.99M | -$11.7M |
Shares Outstanding (Basic) | 57.92M | - | 27.27M | 20.16M | 20.15M | - | 19.51M | - | - | 12.12M |
Shares Outstanding (Diluted) | 57.92M | - | 27.27M | 20.16M | 20.15M | - | 19.51M | - | - | 12.12M |
EPS (Basic) | -$0.32 | - | -$0.55 | -$0.62 | -$0.62 | - | -$0.69 | - | - | -$0.96 |
EPS (Diluted) | -$0.32 | - | -$0.55 | -$0.62 | -$0.62 | - | -$0.69 | - | - | -$0.96 |
EBIT | -$13.07M | -$12.78M | -$13.16M | -$13.03M | -$13.1M | -$14.03M | -$13.52M | -$12.66M | -$13.48M | -$12.34M |
EBITDA | -$6.36M | $15.63M | -$10.45M | -$12.6M | -$12.68M | -$13.62M | -$13.1M | -$12.24M | -$13.04M | -$11.91M |